Market Exclusive

Analyst Activity – HC Wainwright Initiates Coverage On Aerie Pharmaceuticals (NASDAQ:AERI) With a Buy

Analyst Ratings For Aerie Pharmaceuticals (NASDAQ:AERI)

Today, HC Wainwright initiated coverage on Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy with a price target of $78.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Aerie Pharmaceuticals (NASDAQ:AERI)
Aerie Pharmaceuticals (NASDAQ:AERI) has insider ownership of 9.36% and institutional ownership of 97.81%.

Recent Trading Activity for Aerie Pharmaceuticals (NASDAQ:AERI)
Shares of Aerie Pharmaceuticals closed the previous trading session at 54.85 up +1.20 2.24% with 55.17499923706055 shares trading hands.

Exit mobile version